These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23079642)

  • 1. Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.
    Custodi C; Nuti R; Oprea TI; Macchiarulo A
    J Mol Graph Model; 2012 Sep; 38():70-81. PubMed ID: 23079642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment factor analyses on G-protein coupled receptors with known crystal structure.
    Anighoro A; Rastelli G
    J Chem Inf Model; 2013 Apr; 53(4):739-43. PubMed ID: 23484900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
    Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.
    Okuno Y; Tamon A; Yabuuchi H; Niijima S; Minowa Y; Tonomura K; Kunimoto R; Feng C
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D907-12. PubMed ID: 17986454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benchmarking study on virtual ligand screening against homology models of human GPCRs.
    Lim VJY; Du W; Chen YZ; Fan H
    Proteins; 2018 Sep; 86(9):978-989. PubMed ID: 30051928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR agonists and antagonists in the clinic.
    Tyndall JD; Sandilya R
    Med Chem; 2005 Jul; 1(4):405-21. PubMed ID: 16789897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
    Dohlman HG
    J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
    Jazayeri A; Dias JM; Marshall FH
    J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA; Chen J; Cunningham KA; Zhou J
    J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.